Talk:Obstructive lung disease: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
(New page: {{subpages}})
 
imported>Howard C. Berkowitz
(Could have move material in general, but I'm no pulmonologist)
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
{{subpages}}
{{subpages}}
== don't like the red box for asthma long acting B agonists ==
I'm sure I heard on the way to campus this morning on a podcast that the most severe type of asthma (and maybe others) often are treated with long acting B-agonists (in addition to oral and inhaled corticosteroids).  I want to say it is type IV but I'm not sure on the classification system.  I don't think it is appropriate to generalize asthma treatment - it should be broken down more in to the main types of asthma - each with different treatments (even when in a general Obsturctive lung disease article).  Or, at least, something to this effect should be mentioned in the box if it is going to be red.  Thoughts? [[User:Tom Kelly|Tom Kelly]] 11:20, 25 September 2008 (CDT)
:Here's a CME article from today's Medscape, suggesting an increased risk of cardiovascular adverse events with long-acting inhaled beta-agonists, but in COPD: http://www.medscape.com/viewarticle/580980.
:I wonder if there should be a line for short-acting beta-agonists. Are there data showing that use of beta-agonists more for symptom relief than chronically is appropriate. Of course, there could be several more rows, such as cromolyns, leukotriene inhibitors, and xanthines. [[User:Howard C. Berkowitz|Howard C. Berkowitz]] 12:07, 25 September 2008 (CDT)

Latest revision as of 12:07, 25 September 2008

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
To learn how to update the categories for this article, see here. To update categories, edit the metadata template.
 Definition Group of usually progressive lung disorders with overlapping signs and symptoms, including asthma, bronchiectasis, chronic bronchitis, and emphysema. [d] [e]
Checklist and Archives
 Workgroup category Health Sciences [Please add or review categories]
 Subgroup category:  Pulmonary medicine
 Talk Archive none  English language variant American English

don't like the red box for asthma long acting B agonists

I'm sure I heard on the way to campus this morning on a podcast that the most severe type of asthma (and maybe others) often are treated with long acting B-agonists (in addition to oral and inhaled corticosteroids). I want to say it is type IV but I'm not sure on the classification system. I don't think it is appropriate to generalize asthma treatment - it should be broken down more in to the main types of asthma - each with different treatments (even when in a general Obsturctive lung disease article). Or, at least, something to this effect should be mentioned in the box if it is going to be red. Thoughts? Tom Kelly 11:20, 25 September 2008 (CDT)

Here's a CME article from today's Medscape, suggesting an increased risk of cardiovascular adverse events with long-acting inhaled beta-agonists, but in COPD: http://www.medscape.com/viewarticle/580980.
I wonder if there should be a line for short-acting beta-agonists. Are there data showing that use of beta-agonists more for symptom relief than chronically is appropriate. Of course, there could be several more rows, such as cromolyns, leukotriene inhibitors, and xanthines. Howard C. Berkowitz 12:07, 25 September 2008 (CDT)